Immunicum AB (publ) Announces Upcoming Conferences in May and June

Press Release

7 May 2019

Immunicum AB (publ; IMMU.ST) announced today that members of the management team will attend and present at upcoming conferences in May and June.

30^th Annual Cancer Progress Conference
Date: May 7 – 8, 2019
Venue: Convene at 32 Old Slip, New York, USA
Participant: Sijme Zeilemaker

14^th Annual World Advanced Therapies & Regenerative Medicine Congress & Expo 2019
Date: May 15 – 17, 2019
Presentation Date & Time: May 17 ; 14.30 – 14.50 BST
Venue: Business Design Center, London, UK
Participants: Margareth Jorvid, Sharon Longhurst

RedEye Pre-ASCO Seminar
Date: May 28, 2019
Presentation Time: 10.30 CEST
Venue: Mäster Samuelsgatan 42, Stockholm, Sweden
Participant: Carlos de Sousa

Great American-China Bio-Partnering Forum 
Date: May 30 – 31, 2019
Presentation Time: 11.00 – 11.20 CDT
Venue: Renaissance Schaumburg Convention Center Hotel, Chicago, USA
Participant: Carlos de Sousa

Sachs Associates 5^th Annual Immuno-Oncology BD&L and Investment Forum
Date: May 31, 2019
Presentation Time & Location: 11.10 – 11.30 CDT ; Faulkner, Track B
Panel & Time: Revised Strategies for Advanced Therapeutics Panel ; 13.40 CDT
Venue: Waldorf Astoria Chicago Hotel, Chicago, USA
Participants: Carlos de Sousa, Sijme Zeilemaker

2019 ASCO Annual Meeting
Date: May 31–June 4, 2019
Venue: McCormick Place, Chicago, USA
Participants: Carlos de Sousa, Peter Suenaert, Alex Karlsson-Parra, Sijme Zeilemaker

Småbolagsdagen 2019
Date: June 3, 2019
Time: 8.00 – 18.00 CEST
Venue: Sheraton Hotel Tegelbacken 6, Stockholm
Participants: Michaela Gertz

For more information, please contact:

Carlos de Sousa, CEO, Immunicum
Telephone: +46 8 732 8400
E-mail: info@immunicum.com  

Michaela Gertz, CFO, Immunicum
Telephone: +46 70 926 17 75
E-mail: ir@immunicum.com 

Media Relations

Gretchen Schweitzer and Joanne Tudorica
Trophic Communications
Telephone: +49 172 861 8540
E-mail: ir@immunicum.com 

U.S. and International Investor Relations

Thomas Renaud
Arrowhead Business and Investment Decisions, LLC
Telephone: +1 212 619-6889 or +1 917 370-5879
E-mail: thomas.renaud@arrowheadbid.com
Immunicum abid.co page: www.abid.co/OMX.IMMU

Swedish Investor Relations

Jonas Rodny and Carolin Wiken
Paues Åberg Communications
Telephone: +46 190 90 51
E-mail: jonas.rodny@pauesaberg.se or carolin.wiken@pauesaberg.se

Attachment

• 20190507_Immunicum May Conferences_ENG_Final